The Hong Kong stock market's innovative drug sector fell, with Boan Biopharma (06955.HK) falling more than 6%, Zai Lab (09688.HK) falling nearly 4%, CSPC Pharmaceutical Group (01093.HK) falling more than 3%, and many stocks including BeiGene (06160.H

2025-06-26

The Hong Kong stock market's innovative drug sector fell, with Boan Biopharma (06955.HK) falling more than 6%, Zai Lab (09688.HK) falling nearly 4%, CSPC Pharmaceutical Group (01093.HK) falling more than 3%, and many stocks including BeiGene (06160.HK) and Hansoh Pharmaceutical (03692.HK) following suit.